Part of Thermo Fisher Scientific


Olink is dedicated to developing the most advanced solutions to enable new discoveries in human health and disease. Olink’s innovative solutions deliver highly sensitive, precise, and multiplexed protein quantification, giving scientists the power to investigate complex biological processes with complete confidence in their data.

If you are excited about the idea of working for a company committed to innovation and delivering the most powerful solutions for scientific research, we want to hear from you!

Current job openings

About us

Olink’s mission is to accelerate proteomics together with the scientific community to understand real-time biology and gain actionable insights into human health and disease. Our innovative solutions deliver highly sensitive and accurate protein quantification, giving scientists the power to confidently investigate complex biological processes.

Company Values


We seek continuous improvement. We think outside the box. We learn from our mistakes. We work smarter, not harder, and we understand how to navigate through change and use it as a catalyst for new ways of thinking and working.

Company Values

Customer focused

We focus on solving the right problems and prioritize accordingly. We aim to deliver the shortest and fastest solution. We are quality-oriented and transparent to our customers. We adapt to new solutions.

Company Values

We keep our promises

We do what we say we will do. We hold ourselves, and our team, accountable. We set reasonable and realistic expectations around delivery and timing.

Company Values

We do it together

We communicate with our team. We involve the right people at the right time. We share our input, and we are receptive to feedback. We celebrate achieved goals and activities!


  • 2016 – Commercial launch of Olink Proteomics in Uppsala, Sweden.
  • 2016 – Olink opens its first overseas office and service lab in Boston, MA.
  • 2018 – Launch of the Olink Target 96 Neuro Exploratory panel, increasing the library to >1000 assays.
  • 2019 – Publications citing Olink reach 500.
  • 2020 – Launch of the Olink Explore platform with NGS readout.
  • 2020 – Olink acquires Agrisera.
  • 2021 – Olink listed on NASDAQ.
  • 2021 – Launch of the first instrument, Olink Signature Q100.
  • 2022 – Launch of Olink Insight and Olink Flex.
  • 2022 – More than 1000 publications citing Olink.
  • 2022 – Olink reaches 500+ employees.

Olink is an equal opportunity employer

At Olink we don’t just accept difference – we celebrate it, we embrace it, and we thrive on it to the benefit of our employees. Olink is an equal opportunity employer. Employment at Olink is based exclusively on a person’s experience, merit and qualifications for the position. Olink does not discriminate against any employee or applicant because of race, creed, colour, religion, gender, sexual orientation, gender identity/expression, national origin, disability, age, genetic information, veteran status, marital status, pregnancy or any other basis protected by law.

It is Olink’s policy to comply with all applicable national, state and local laws pertaining to non-discrimination and equal opportunity. The Company’s EEO policy has the full and complete support of the it’s individuals and Executive Leadership.

Olink is currently present in 16 countries around the globe, and we have employees from over 50 different nationalities.